TumourVue

TumourVue is a verified, high-potential medical device project (AI/AR for tumor resection) originating from Cambridge University and funded by the Medtech Accelerator. However, the submission quality is critically poor: the description is copied from the accelerator's website, claims of audience reach ('everyone') and traction ('most people have used my product') are patently false or exaggerated, and the URL is generic. While the underlying technology and clinical utility are significant (saving NHS costs, improving cancer outcomes), the score is heavily penalized due to the lack of specific, accurate evidence provided by the submitter and the reliance on external search for verification.